These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine. Ährlund-Richter A, Cheng L, Hu YOO, Svensson M, Pennhag AAL, Ursu RG, Haeggblom L, Grün N, Ramqvist T, Engstrand L, Dalianis T, Du J. Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454 [Abstract] [Full Text] [Related]
4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M. Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297 [Abstract] [Full Text] [Related]
6. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology. Ali MAM, Bedair RN, Abd El Atti RM. Cancer Cytopathol; 2019 Sep 31; 127(9):567-577. PubMed ID: 31390155 [Abstract] [Full Text] [Related]
8. Impact of HPV vaccination with Gardasil® in Switzerland. Jacot-Guillarmod M, Pasquier J, Greub G, Bongiovanni M, Achtari C, Sahli R. BMC Infect Dis; 2017 Dec 22; 17(1):790. PubMed ID: 29273004 [Abstract] [Full Text] [Related]
10. Introduction of a National HPV vaccination program into Bhutan. Dorji T, Tshomo U, Phuntsho S, Tamang TD, Tshokey T, Baussano I, Franceschi S, Clifford G. Vaccine; 2015 Jul 17; 33(31):3726-30. PubMed ID: 26057136 [Abstract] [Full Text] [Related]
11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe. Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S. Vaccine; 2013 Dec 31; 31 Suppl 7():H59-70. PubMed ID: 24332298 [Abstract] [Full Text] [Related]
14. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy. Carozzi F, Puliti D, Ocello C, Anastasio PS, Moliterni EA, Perinetti E, Serradell L, Burroni E, Confortini M, Mantellini P, Zappa M, Dominiak-Felden G. BMC Infect Dis; 2018 Jan 15; 18(1):38. PubMed ID: 29334901 [Abstract] [Full Text] [Related]
19. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study. Guettiti H, Ennaifer E, Attia L, Chelly D, Alaya NB, Aissa RB, Laassili T, Boubaker S. Asian Pac J Cancer Prev; 2014 Jan 15; 15(21):9361-5. PubMed ID: 25422225 [Abstract] [Full Text] [Related]